Keefe, Bruyette & Woods Reiterates Outperform on MetLife, Lowers Price Target to $80
Portfolio Pulse from Benzinga Newsdesk
Keefe, Bruyette & Woods analyst Ryan Krueger reiterates an Outperform rating on MetLife (NYSE:MET) and lowers the price target from $86 to $80.
June 09, 2023 | 4:36 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Keefe, Bruyette & Woods analyst Ryan Krueger maintains an Outperform rating on MetLife, but lowers the price target from $86 to $80.
The news of Keefe, Bruyette & Woods analyst Ryan Krueger reiterating an Outperform rating on MetLife is positive for the company. However, the lowering of the price target from $86 to $80 may create some uncertainty among investors. The overall impact on the stock price is expected to be neutral in the short term, as the positive rating is balanced by the reduced price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100